Oncology Views & Analysis

Views & Analysis

Deep Dive: The Future of Oncology

This year’s ASCO showed us that while COVID-19 might be front and centre of everyone’s minds, the desire to see real change in cancer treatment hasn’t diminished. In this issue

Views & Analysis

COVID-19 and cancer: can pharma stymie the pandemic’s impact...

The COVID-19 pandemic may lead to increased cases of cancer mortality – what can biopharma companies do to help lessen the impact?

Views & Analysis

Bringing men out of isolation after a cancer diagnosis

Studies show that men often isolate themselves when diagnosed with cancer – which can have severe impacts on mental health and outcomes.

Views & Analysis

ASCO 2020 round-up: Virtual conference still delivers the dr...

ASCO may have been virtual this year because of the COVID-19 pandemic, but there were still some show-stopping moments, reports Richard Staines. This time of year oncologists from

Oncology

Preparing for the next decade of innovation in immuno-oncolo...

Immuno-oncology has seen some striking clinical advances in the 10 years since the approval of the first therapeutic cancer vaccine, but it’s a field that doesn’t stand still.

Oncology

ASCO 2020 virtual annual meeting - day 3

Our live coverage from this year’s slimmed down, virtual version of the American Society of Clinical Oncology (ASCO) annual meeting continues at 8am (ET) as we move into the third and final

Deep Dive: The Future of Oncology

COVID-19 and cancer: can pharma stymie the pandemic’s impact...

Bringing men out of isolation after a cancer diagnosis

ASCO 2020 round-up: Virtual conference still delivers the dr...

Preparing for the next decade of innovation in immuno-oncolo...

ASCO 2020 virtual annual meeting - day 3

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

Views & Analysis

Editor's Picks